Preliminary Experience of Viabahn Stent Graft Inside the Occluded Prosthetic Bypass Graft for the Treatment of Above Knee Femoropopliteal Bypass Occlusion

Naoki Fujimura, Hideaki Obara, Kazuomi Iwasa, Tsutomu Hattori, Hiroshi Yamamoto, Susumu Watada, Taira Kobayashi, Nobuhiro Suematsu, Hiroshi Mitsuoka, Yoshimitsu Soga, Tatsuya Nakama, Ryohei Sakamoto, Shigeo Ichihashi

Research output: Contribution to journalArticle

Abstract

Purpose: To describe a multi-center preliminary experience of treating prosthetic above knee femoropopliteal (AKFP) bypass occlusion by placing a Viabahn stent graft inside the occluded prosthetic bypass graft. Materials and Methods: Retrospective analysis of consecutive 14 patients (mean age 73.2 ± 10.2, 78.6% male) receiving Viabahn stent graft inside the occluded prosthetic bypass graft for the treatment of prosthetic AKFP bypass occlusion in the collaborating hospitals from November 2016 to June 2019 was performed. Results: Technical success was achieved in all patients. Mean lesion length was 34.0 ± 3.5 cm, concomitant thrombectomy or thrombus aspiration was performed in 11 patients (78.6%), and average of 1.57 ± 0.65 Viabahn stent grafts were used. Mean ankle–brachial index improved from 0.24 ± 0.23 to 0.98 ± 0.14 after the treatment. All patients had preoperative ischemic symptoms with 9 patients (64.3%) having Rutherford class > 4 symptoms; however, all preoperative symptoms resolved after the treatment. During the mean follow-up of 450.9 ± 234.7 days, there were two target lesion revascularizations, leading to a primary patency rate of 92.9% and a secondary patency of 100.0% at 1 year. Conclusion: Placing a Viabahn stent graft inside the occluded prosthetic bypass graft for the treatment of prosthetic AKFP bypass occlusion appears to be effective from our preliminary experience. Even though sample size is limited in our study, it may be considered as a potential treatment option before surgical reintervention.

Original languageEnglish
JournalCardiovascular and Interventional Radiology
DOIs
Publication statusAccepted/In press - 2019 Jan 1

Fingerprint

Stents
Knee
Transplants
Therapeutics
Thrombectomy
Sample Size
Thrombosis

Keywords

  • Above knee femoropopliteal bypass occlusion
  • Prosthetic graft
  • Viabahn stent graft

ASJC Scopus subject areas

  • Radiology Nuclear Medicine and imaging
  • Cardiology and Cardiovascular Medicine

Cite this

Preliminary Experience of Viabahn Stent Graft Inside the Occluded Prosthetic Bypass Graft for the Treatment of Above Knee Femoropopliteal Bypass Occlusion. / Fujimura, Naoki; Obara, Hideaki; Iwasa, Kazuomi; Hattori, Tsutomu; Yamamoto, Hiroshi; Watada, Susumu; Kobayashi, Taira; Suematsu, Nobuhiro; Mitsuoka, Hiroshi; Soga, Yoshimitsu; Nakama, Tatsuya; Sakamoto, Ryohei; Ichihashi, Shigeo.

In: Cardiovascular and Interventional Radiology, 01.01.2019.

Research output: Contribution to journalArticle

Fujimura, Naoki ; Obara, Hideaki ; Iwasa, Kazuomi ; Hattori, Tsutomu ; Yamamoto, Hiroshi ; Watada, Susumu ; Kobayashi, Taira ; Suematsu, Nobuhiro ; Mitsuoka, Hiroshi ; Soga, Yoshimitsu ; Nakama, Tatsuya ; Sakamoto, Ryohei ; Ichihashi, Shigeo. / Preliminary Experience of Viabahn Stent Graft Inside the Occluded Prosthetic Bypass Graft for the Treatment of Above Knee Femoropopliteal Bypass Occlusion. In: Cardiovascular and Interventional Radiology. 2019.
@article{cc983daaac2a4f049befeaa11f560e8b,
title = "Preliminary Experience of Viabahn Stent Graft Inside the Occluded Prosthetic Bypass Graft for the Treatment of Above Knee Femoropopliteal Bypass Occlusion",
abstract = "Purpose: To describe a multi-center preliminary experience of treating prosthetic above knee femoropopliteal (AKFP) bypass occlusion by placing a Viabahn stent graft inside the occluded prosthetic bypass graft. Materials and Methods: Retrospective analysis of consecutive 14 patients (mean age 73.2 ± 10.2, 78.6{\%} male) receiving Viabahn stent graft inside the occluded prosthetic bypass graft for the treatment of prosthetic AKFP bypass occlusion in the collaborating hospitals from November 2016 to June 2019 was performed. Results: Technical success was achieved in all patients. Mean lesion length was 34.0 ± 3.5 cm, concomitant thrombectomy or thrombus aspiration was performed in 11 patients (78.6{\%}), and average of 1.57 ± 0.65 Viabahn stent grafts were used. Mean ankle–brachial index improved from 0.24 ± 0.23 to 0.98 ± 0.14 after the treatment. All patients had preoperative ischemic symptoms with 9 patients (64.3{\%}) having Rutherford class > 4 symptoms; however, all preoperative symptoms resolved after the treatment. During the mean follow-up of 450.9 ± 234.7 days, there were two target lesion revascularizations, leading to a primary patency rate of 92.9{\%} and a secondary patency of 100.0{\%} at 1 year. Conclusion: Placing a Viabahn stent graft inside the occluded prosthetic bypass graft for the treatment of prosthetic AKFP bypass occlusion appears to be effective from our preliminary experience. Even though sample size is limited in our study, it may be considered as a potential treatment option before surgical reintervention.",
keywords = "Above knee femoropopliteal bypass occlusion, Prosthetic graft, Viabahn stent graft",
author = "Naoki Fujimura and Hideaki Obara and Kazuomi Iwasa and Tsutomu Hattori and Hiroshi Yamamoto and Susumu Watada and Taira Kobayashi and Nobuhiro Suematsu and Hiroshi Mitsuoka and Yoshimitsu Soga and Tatsuya Nakama and Ryohei Sakamoto and Shigeo Ichihashi",
year = "2019",
month = "1",
day = "1",
doi = "10.1007/s00270-019-02376-6",
language = "English",
journal = "CardioVascular and Interventional Radiology",
issn = "7415-5101",
publisher = "Springer Verlag",

}

TY - JOUR

T1 - Preliminary Experience of Viabahn Stent Graft Inside the Occluded Prosthetic Bypass Graft for the Treatment of Above Knee Femoropopliteal Bypass Occlusion

AU - Fujimura, Naoki

AU - Obara, Hideaki

AU - Iwasa, Kazuomi

AU - Hattori, Tsutomu

AU - Yamamoto, Hiroshi

AU - Watada, Susumu

AU - Kobayashi, Taira

AU - Suematsu, Nobuhiro

AU - Mitsuoka, Hiroshi

AU - Soga, Yoshimitsu

AU - Nakama, Tatsuya

AU - Sakamoto, Ryohei

AU - Ichihashi, Shigeo

PY - 2019/1/1

Y1 - 2019/1/1

N2 - Purpose: To describe a multi-center preliminary experience of treating prosthetic above knee femoropopliteal (AKFP) bypass occlusion by placing a Viabahn stent graft inside the occluded prosthetic bypass graft. Materials and Methods: Retrospective analysis of consecutive 14 patients (mean age 73.2 ± 10.2, 78.6% male) receiving Viabahn stent graft inside the occluded prosthetic bypass graft for the treatment of prosthetic AKFP bypass occlusion in the collaborating hospitals from November 2016 to June 2019 was performed. Results: Technical success was achieved in all patients. Mean lesion length was 34.0 ± 3.5 cm, concomitant thrombectomy or thrombus aspiration was performed in 11 patients (78.6%), and average of 1.57 ± 0.65 Viabahn stent grafts were used. Mean ankle–brachial index improved from 0.24 ± 0.23 to 0.98 ± 0.14 after the treatment. All patients had preoperative ischemic symptoms with 9 patients (64.3%) having Rutherford class > 4 symptoms; however, all preoperative symptoms resolved after the treatment. During the mean follow-up of 450.9 ± 234.7 days, there were two target lesion revascularizations, leading to a primary patency rate of 92.9% and a secondary patency of 100.0% at 1 year. Conclusion: Placing a Viabahn stent graft inside the occluded prosthetic bypass graft for the treatment of prosthetic AKFP bypass occlusion appears to be effective from our preliminary experience. Even though sample size is limited in our study, it may be considered as a potential treatment option before surgical reintervention.

AB - Purpose: To describe a multi-center preliminary experience of treating prosthetic above knee femoropopliteal (AKFP) bypass occlusion by placing a Viabahn stent graft inside the occluded prosthetic bypass graft. Materials and Methods: Retrospective analysis of consecutive 14 patients (mean age 73.2 ± 10.2, 78.6% male) receiving Viabahn stent graft inside the occluded prosthetic bypass graft for the treatment of prosthetic AKFP bypass occlusion in the collaborating hospitals from November 2016 to June 2019 was performed. Results: Technical success was achieved in all patients. Mean lesion length was 34.0 ± 3.5 cm, concomitant thrombectomy or thrombus aspiration was performed in 11 patients (78.6%), and average of 1.57 ± 0.65 Viabahn stent grafts were used. Mean ankle–brachial index improved from 0.24 ± 0.23 to 0.98 ± 0.14 after the treatment. All patients had preoperative ischemic symptoms with 9 patients (64.3%) having Rutherford class > 4 symptoms; however, all preoperative symptoms resolved after the treatment. During the mean follow-up of 450.9 ± 234.7 days, there were two target lesion revascularizations, leading to a primary patency rate of 92.9% and a secondary patency of 100.0% at 1 year. Conclusion: Placing a Viabahn stent graft inside the occluded prosthetic bypass graft for the treatment of prosthetic AKFP bypass occlusion appears to be effective from our preliminary experience. Even though sample size is limited in our study, it may be considered as a potential treatment option before surgical reintervention.

KW - Above knee femoropopliteal bypass occlusion

KW - Prosthetic graft

KW - Viabahn stent graft

UR - http://www.scopus.com/inward/record.url?scp=85075047041&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85075047041&partnerID=8YFLogxK

U2 - 10.1007/s00270-019-02376-6

DO - 10.1007/s00270-019-02376-6

M3 - Article

C2 - 31728634

AN - SCOPUS:85075047041

JO - CardioVascular and Interventional Radiology

JF - CardioVascular and Interventional Radiology

SN - 7415-5101

ER -